Rona Therapeutics
Shanghai
About Rona Therapeutics
Rona Therapeutics is an RNA therapeutics platform that enables the discovery, development, and commercialization of modular and programmable RNA medicines. They provide services that include oligonucleotide therapies, RNA editing, and polymeric molecules. Rona Therapeutics provides the opportunity to develop transformative RNA therapies and disrupt the trajectory of disease treatment across multiple therapeutic areas. Rona Therapeutics is dedicated to true innovation, assisting patients in living healthier and longer lives, and creating an environment that encourages great people to do great things.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $93.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2025)
- Website: ronatherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rona-therapeutics-59558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.